Poonam Mishra, Jeffrey Murray, Debra Birnkrant – 7 May 2015 – Therapeutic options for treatment of chronic hepatitis C have improved substantially since the approval of direct‐acting antiviral agents (DAAs). Several interferon (IFN)‐free or IFN‐ and ribavirin (RBV)‐free treatment regimens with shorter durations and improved efficacy and safety profiles are now available. The U.S.

Anitha Yadav, Hugo E. Vargas – 7 May 2015 – Watch a video presentation of this article

Eamonn M.M. Quigley – 7 May 2015 – Watch a video presentation of this article

James H. Tabibian, Cyril Varghese, Steven P. O'Hara, Nicholas F. LaRusso – 7 May 2015 – Watch a video presentation of this article

Francisco Guarner – 7 May 2015 – Watch a video presentation of this article

Zheng Zhang, Bin Gao, Fu‐Sheng Wang – 7 May 2015

Eric F. Martin, Christopher O'Brien – 7 May 2015 – Watch a video presentation of this article

Anitha Yadav, Hugo E. Vargas – 7 May 2015 – Watch a video presentation of this article

Thomas D. Shupe, Bryon E. Petersen – 7 May 2015

Maria Reig, Jordi Bruix – 7 May 2015